Maidenhair tree

Clinical Notes. Adjunctive treatment for asthma d/t inhibition of paroxysmal atrial fibrillation, which results in decreased bronchoconstriction For Alzheimer's and dementia d/t antioxidant activity in brain and central nervous system Treats migraines d/t its ability to stabilize serotonin levels and platelets in brain Circulatory stimulant, increasing perfusion by relaxing blood vessel endothelium while maintaining tone Simulates blood flow through the smaller blood vessels Has been shown to reduce cerebral ed and normalize brain glucose utilization and ATP production post ischemic event Should be dosed 6 weeks before re-evaluation.

safety_bleeding_interaction. Generally well tolerated over long, widespread use; main adverse effects are mild (headache, dizziness, GI discomfort), but its antiplatelet activity may potentiate anticoagulant/antiplatelet medications and increase bleeding risk.

anticancer_preclinical. Shows antioxidant, anti-angiogenic, and gene-regulatory anticancer activity in preclinical models, with ginkgolide B inhibiting tumor cell proliferation and effects mediated partly via cathepsin B inhibition.

dementia_cognition. Standardized leaf extract improves cognition, daily function, and global clinical status in mild-to-moderate dementia and cognitive impairment, with meta-analysis showing benefit over placebo, most consistently at 240 mg/day.